Hacker News new | past | comments | ask | show | jobs | submit login

You're assuming that most of the "extra" money goes back in research and not to shareholders and management bonuses

Given how pharma companies operate, I kinda doubt it.




No assumptions. The rand article addresses that directly.




Consider applying for YC's Spring batch! Applications are open till Feb 11.

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: